{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:00:52Z","timestamp":1792101652008,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY015240"],"award-info":[{"award-number":["R01EY015240"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY028916"],"award-info":[{"award-number":["R01EY028916"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007826","name":"American Glaucoma Society","doi-asserted-by":"publisher","award":["T32EY007035"],"award-info":[{"award-number":["T32EY007035"]}],"id":[{"id":"10.13039\/100007826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007826","name":"American Glaucoma Society","doi-asserted-by":"publisher","award":["T32GM007170"],"award-info":[{"award-number":["T32GM007170"]}],"id":[{"id":"10.13039\/100007826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008556","name":"Paul MacKall and Evanina Bell MacKall Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.celrep.2020.108271","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T15:23:11Z","timestamp":1604416991000},"page":"108271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7535-1073","authenticated-orcid":false,"given":"Jacob K.","family":"Sterling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-948X","authenticated-orcid":false,"given":"Modupe O.","family":"Adetunji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samyuktha","family":"Guttha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert R.","family":"Bargoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4280-1397","authenticated-orcid":false,"given":"Katherine E.","family":"Uyhazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7527-3121","authenticated-orcid":false,"given":"Ahmara G.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Dunaief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-0401","authenticated-orcid":false,"given":"Qi N.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.celrep.2020.108271_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/dom.13162","article-title":"A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomized controlled trials","volume":"20","author":"Aroda","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.celrep.2020.108271_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","article-title":"The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action","volume":"21","author":"Athauda","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.celrep.2020.108271_bib3","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","article-title":"New tools for studying microglia in the mouse and human CNS","volume":"113","author":"Bennett","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2020.108271_bib4","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.ymthe.2018.08.017","article-title":"Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma","volume":"26","author":"Bosco","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celrep.2020.108271_bib5","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/j.1442-9071.2011.02595.x","article-title":"Association of tumour necrosis factor-alpha -308 G\/A polymorphism with primary open-angle glaucoma","volume":"40","author":"Bozkurt","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.celrep.2020.108271_bib6","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1523\/JNEUROSCI.4443-07.2008","article-title":"Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma","volume":"28","author":"Buckingham","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.celrep.2020.108271_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-7407-8_3","article-title":"The Microbead Occlusion Model of Ocular Hypertension in Mice","volume":"1695","author":"Calkins","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.celrep.2020.108271_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrn3484","article-title":"Emerging roles of astrocytes in neural circuit development","volume":"14","author":"Clarke","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.celrep.2020.108271_bib9","doi-asserted-by":"crossref","first-page":"107961","DOI":"10.1016\/j.exer.2020.107961","article-title":"Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma","volume":"193","author":"Cui","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.celrep.2020.108271_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: beyond the surface","volume":"63","author":"Daruich","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.celrep.2020.108271_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.celrep.2020.108271_bib12","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1167\/iovs.09-4974","article-title":"Association of polymorphisms of tumor necrosis factor and tumor protein p53 with primary open-angle glaucoma","volume":"51","author":"Fan","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.celrep.2020.108271_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G\u2217Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.celrep.2020.108271_bib14","doi-asserted-by":"crossref","first-page":"107776","DOI":"10.1016\/j.celrep.2020.107776","article-title":"Neurotoxic reactive astrocytes drive neuronal death after retinal injury","volume":"31","author":"Guttenplan","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2020.108271_bib15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI44646","article-title":"Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma","volume":"121","author":"Howell","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2020.108271_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2014.07.016","article-title":"Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma","volume":"71","author":"Howell","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"109","key":"10.1016\/j.celrep.2020.108271_bib17","first-page":"e53731","article-title":"A magnetic microbead occlusion model to induce ocular hypertension-dependent glaucoma in mice","author":"Ito","year":"2016","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.celrep.2020.108271_bib18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/glia.23140","article-title":"Anti-ACSA-2 defines a novel monoclonal antibody for prospective isolation of living neonatal and adult astrocytes","volume":"65","author":"Kantzer","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.celrep.2020.108271_bib19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.preteyeres.2008.09.003","article-title":"Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management","volume":"27","author":"Kaur","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.celrep.2020.108271_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/dme.13296","article-title":"Visual complications in diabetes mellitus: beyond retinopathy","volume":"34","author":"Khan","year":"2017","journal-title":"Diabet. Med."},{"key":"10.1016\/j.celrep.2020.108271_bib21","first-page":"340","article-title":"Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood- retina barrier during chronic inflammation","volume":"15","author":"Kokona","year":"2018"},{"key":"10.1016\/j.celrep.2020.108271_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnins.2017.00045","article-title":"Oral delivery of a synthetic sterol reduces axonopathy and inflammation in a rodent model of glaucoma","volume":"11","author":"Lambert","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.celrep.2020.108271_bib23","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1038\/s41598-020-65374-6","article-title":"Of mice and monkeys: neuroprotective efficacy of the p38 inhibitor BIRB 796 depends on model duration in experimental glaucoma","volume":"10","author":"Lambert","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2020.108271_bib24","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/02713683.2016.1276193","article-title":"Visual field progression is associated with systemic concentration of macrophage chemoattractant protein-1 in normal-tension glaucoma","volume":"42","author":"Lee","year":"2017","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.celrep.2020.108271_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2020.108271_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2020.108271_bib27","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00417-018-4081-y","article-title":"CD163+ macrophages infiltrate axon bundles of postmortem optic nerves with glaucoma","volume":"256","author":"Margeta","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.celrep.2020.108271_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2350-11-99","article-title":"Association of IL1A and IL1B loci with primary open angle glaucoma","volume":"11","author":"Mookherjee","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.celrep.2020.108271_bib29","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1167\/iovs.08-3267","article-title":"Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas","volume":"50","author":"Nadal-Nicol\u00e1s","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.celrep.2020.108271_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41433-018-0227-8","article-title":"21st century glaucoma care","volume":"33","author":"Quigley","year":"2019","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.celrep.2020.108271_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fncel.2016.00140","article-title":"Simultaneous complement response via lectin pathway in retina and optic nerve in an experimental autoimmune glaucoma model","volume":"10","author":"Reinehr","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.celrep.2020.108271_bib32","doi-asserted-by":"crossref","first-page":"E2393","DOI":"10.1073\/pnas.1714888115","article-title":"Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma","volume":"115","author":"Risner","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2020.108271_bib33","doi-asserted-by":"crossref","first-page":"107873","DOI":"10.1016\/j.exer.2019.107873","article-title":"Elevated ocular pressure reduces voltage-gated sodium channel NaV1.2 protein expression in retinal ganglion cell axons","volume":"190","author":"Risner","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.celrep.2020.108271_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1167\/iovs.09-3947","article-title":"The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice","volume":"51","author":"Sappington","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.celrep.2020.108271_bib35","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1167\/iovs.05-0830","article-title":"Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes","volume":"47","author":"Stasi","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.celrep.2020.108271_bib36","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2020.108271_bib37","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.celrep.2020.108271_bib38","article-title":"Suppression of homeostatic gene expression and increased expression of metabolism-related genes are early features of glaucoma in optic nerve head microglia","author":"Tribble","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2020.108271_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13041-020-00603-7","article-title":"Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA\/2\u2009J mice","volume":"13","author":"Tribble","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.celrep.2020.108271_bib40","article-title":"When is a control not a control? Reactive microglia occur throughout the control contralateral visual pathway in experimental glaucoma","author":"Tribble","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2020.108271_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","article-title":"Glia-neuron interactions in the mammalian retina","volume":"51","author":"Vecino","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.celrep.2020.108271_bib42","first-page":"1380","article-title":"Polymorphism in the IL-1alpha (-889) locus associated with elevated risk of primary open angle glaucoma","volume":"12","author":"Wang","year":"2006","journal-title":"Mol. Vis."},{"key":"10.1016\/j.celrep.2020.108271_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-016-0091-6","article-title":"Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma","volume":"11","author":"Williams","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2020.108271_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.exer.2017.02.014","article-title":"Neuroinflammation in glaucoma: a new opportunity","volume":"157","author":"Williams","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.celrep.2020.108271_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-018-0303-3","article-title":"Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA\/2J glaucoma","volume":"14","author":"Williams","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2020.108271_bib46","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2020.108271_bib47","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","article-title":"Genomic analysis of reactive astrogliosis","volume":"32","author":"Zamanian","year":"2012","journal-title":"J.\u00a0Neurosci."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124720312602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124720312602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:08:22Z","timestamp":1761908902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124720312602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2211124720312602"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2020.108271","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.18.146720","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2020.108271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"108271"}}